Mariam Oladejo
Immunotherapeutics and Biotechnology
 |
|
Biography
Mariam Oladejo completed her Bachelor of Pharmacy (BPharm) degree from Obafemi Awolowo University, Ile-Ife, Nigeria in 2016. She joined the Graduate Program in Pharmaceutical Sciences as a Doctor of Philosophy (PhD) student in August of 2019, and is presently working in the laboratory of Dr. Laurence Wood with the Department of Immunotherapeutics and Biotechnology in Abilene.
Education:
- BPharm: Obafemi Awolowo University, Ile-Ife, Nigeria, 2016
Research Interests:
Listeria monocytogenes-based immunotherapy, targeted cancer therapy, cancer immunology.
Publications:
- Oladejo M, Nguyen HM, Seah H, Datta A, Wood LM. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma. Cancer Immunol Immunother. 2023 Jun; 72(6):1633-1646. Epub 2022 Dec 31.
- Nguyen HM, Gaikwad S, Oladejo M, Agrawal MY, Srivastava SK, Wood LM. Interferon stimulated gene 15 (ISG15) in cancer: An update. Cancer Lett. 2023 Mar 1; 556:216080. Epub 2023 Feb 1.
- Nguyen HM, Gaikwad S, Oladejo M, Paulishak W, Wood LM. Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer. Cancers (Basel). 2023 Feb 15; 15(4):1237.
- Oladejo M, Paulishak W, Wood L. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines. Semin Cancer Biol. 2023 Jan; 88:81-95. Epub 2022 Dec 13.
- Nguyen HM, Paulishak W, Oladejo M, Wood L. Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches. Breast Cancer. 2023 Mar; 30(2):167-186. Epub Nov 18.
- Oladejo M, Nguyen HM, Silwal A, Reese B, Paulishak W, Markiewski MM, Wood LM. Listeria-based immunotherapy directed against CD105 exerts antiangiogenic and anti-tumor efficacy in renal cell carcinoma. Front Immunol. 2022 Nov 11; 13:1038807.
- Oladejo M, Paterson Y, Wood LM. Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies. Front Immunol. 2021 Apr 14; 12:642316.
Presentations:
- Mariam Oladejo and Laurence Wood. "Listeria-based immunotherapy sculpts CD8+ T cell response in the tumor microenvironment to control renal cell carcinoma". Society for Immunotherapy of Cancer (SITC), Boston, MA; November 2022.
- Mariam Oladejo and Laurence M. Wood. "A Listeria-Based Vaccine Directed against CD 105 in Renal Cell Carcinoma". 19th Annual Research Days, Ογ½ΆΦ±²₯ Jerry H Hodge School of Pharmacy, Office of Sciences in Amarillo, event at Lubbock, TX; June 2022.
- Mariam Oladejo and Laurence M Wood. "Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity, and Therapeutic Response in Renal Cell Carcinoma". Society for Immunotherapy of Cancer (SITC) 2022 Tumor Immune Microenvironment: A Holistic Approach, San Diego, CA; April 2022.
- Mariam Oladejo and Laurence. M. Wood. "Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity and Therapeutic Response in Renal Cell Carcinoma". Student Research Week, Ογ½ΆΦ±²₯ Graduate School of Biomedical Sciences, Lubbock; March 2022.
- Mariam Oladejo, Min Xie, Hannah Seah , Britney Reese and Laurence. M. Wood. "Characterization and Therapeutic Targeting of CD105 in Renal Cell Carcinoma". Research Days, Ογ½ΆΦ±²₯ Jerry H Hodge School of Pharmacy, Amarillo (virtual); June 2021.
Seminars:
- 03/15/2023 "CD105 and ISG16 as Modulators of Immunotherapeutic Response in Renal Cell Carcinoma" [Dissertation Defense, presentation counted as Seminar credit]
- 10/15/2021 "A Multipotent Listeria-Based Vaccine against EBV-Associated Colorectal Cancer" [Oral Qualifying Exam, public presentation counted as Seminar credit]
- 04/16/2021 "Characterization and Therapeutic Targeting of CD105 in Renal Cell Carcinoma (RCC)"
Awards/Scholarships:
- Graduate Research Grant, The Honor Society of Phi Kappa Phi (International), February 2023.
- Love of Learning Award, The Honor Society of Phi Kappa Phi (International), September 2022.
- Howard Hughes Medical Institute (HHMI) Scholarship, 100% reduction of registration fees, Jackson Lab's, Farmington, Connecticut (virtual); August 2022.
- Travel Grant Award, Cayman Chemical Co., Society for Immunotherapy of Cancer (SITC) 2022 Tumor Immune Microenvironment: A Holistic Approach, San Diego, CA; April 2022.
- Mary Lou Clements-Mann Endowed Scholarship, Ογ½ΆΦ±²₯ Graduate School of Biomedical Sciences (GSBS), Fall 2021.
Memberships:
- The Honor Society of Phi Kappa Phi (International), Ογ½ΆΦ±²₯ Chapter, 2022-present.
- Society for Immunotherapy of Cancer (SITC), 2022-present.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ογ½ΆΦ±²₯, 2019-present.